Zobrazeno 1 - 10
of 47
pro vyhledávání: '"S. Christopher Jones"'
Autor:
Kathleen M. Sullivan, Graça M. Dores, Afrouz Nayernama, Tatiana M. Prowell, Shan M. Pradhan, Christy Osgood, S. Christopher Jones
Publikováno v:
JAMA oncology. 8(10)
This case series investigates reports of 20 patients with colitis temporally associated with alpelisib use.
Publikováno v:
Drug Safety. 43:1267-1276
Ulipristal acetate (ulipristal) is a selective progesterone receptor modulator that has been marketed for daily use in Europe and Canada to reduce symptoms caused by uterine fibroids. Long-term use of some other members of this class of 19-norprogest
Autor:
Lynda McCulley, S. Christopher Jones, Susan J. Bersoff-Matcha, Page E. Crew, Peter E. Waldron, Lucy A McNamara
Publikováno v:
J Infect
Publikováno v:
American journal of hematologyREFERENCES. 97(4)
Autor:
Michelle C, Nadeau Nguyen, Daniel, Woronow, Bailee, Binks, Afrouz, Nayernama, S Christopher, Jones
Publikováno v:
JACC: CardioOncology
Autor:
Michelle Nadeau Nguyen, Laleh Amiri-Kordestani, Daniel Woronow, Afrouz Nayernama, Michael Brave, S. Christopher Jones, Sundeep Agrawal, Connie Cheng
Publikováno v:
Vascular medicine (London, England). 26(5)
The US Food and Drug Administration (FDA) has approved multiple systemic vascular endothelial growth factor (VEGF) inhibitors since 2004 to treat various malignancies. Inhibition of the VEGF signaling pathway can result in impairment of vascular wall
Autor:
Cheng, Connie, Nguyen, Michelle Nadeau, Afrouz Nayernama, S Christopher Jones, Brave, Michael, Sundeep Agrawal, Amiri-Kordestani, Laleh, Woronow, Daniel
Supplemental material, sj-docx-1-vmj-10.1177_1358863X211006470 for Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6522d8b6af84eabf5263647593dff5de
Publikováno v:
Drug Saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65aa7b416d8f8f9137db73df87a8273b
https://europepmc.org/articles/PMC7574883/
https://europepmc.org/articles/PMC7574883/
Autor:
Afrouz Nayernama, Bindu Kanapuru, Nicole J. Gormley, Michelle Nadeau Nguyen, S. Christopher Jones, Peter E. Waldron
Publikováno v:
American journal of hematology. 95(9)
Autor:
Cindy Kortepeter, S. Christopher Jones, Kathryn K. Marwitz, Gerald J. Dal Pan, Monica A. Muñoz
Publikováno v:
Drug safety. 43(5)
Adverse reactions with an outcome of death are inherently important for pharmacovigilance organizations to evaluate. Prior efforts to systematically evaluate individual case safety reports (ICSRs) with an outcome of death have been limited to high-le